EMPA-REG HF Event Reduction Index Calculator
Estimate absolute risk reduction
Enter the estimated annual risk of heart failure hospitalization and a projection period.
Enter values to calculate
The estimate will appear here. This is a simplified projection, not a validated individual treatment-benefit prediction.
| Measure | Projected value |
|---|---|
| Risk without treatment over the selected period | — |
| Risk with the assumed effect of empagliflozin | — |
| Absolute risk reduction (ARR) | — |
| Illustrative number needed to treat (NNT) | — |
About this estimate
The EMPA-REG OUTCOME trial studied empagliflozin in people with type 2 diabetes and established cardiovascular disease. In the trial, hospitalization for heart failure occurred in 2.7% of participants receiving empagliflozin and 4.1% receiving placebo; the hazard ratio was 0.65 (95% CI 0.50–0.85).
This tool applies a simplified 35% relative reduction assumption to a user-entered annual heart failure hospitalization risk. It compounds the annual risk over the selected period, assuming the same baseline risk and treatment effect each year. That assumption is mathematical and has not been validated as an individualized prediction model.
How to interpret the result
- The ARR is the modeled difference between projected risks, expressed in percentage points.
- The NNT is the reciprocal of the modeled ARR over the selected period, rounded up; it is illustrative and should not be interpreted as a trial-derived NNT.
- Absolute benefit depends on baseline risk and the time horizon. Uncertainty increases when extrapolating beyond the trial follow-up or population.
Important scope limitation
The 35% estimate refers to hospitalization for heart failure in EMPA-REG OUTCOME. It should not be applied to cardiovascular death or interpreted as a validated effect for a combined endpoint. The trial population and background care may differ from an individual patient or other clinical populations.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.